blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2544537

EP2544537 - PARENTERAL FORMULATIONS OF MACROLIDE ANTIBIOTICS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  16.03.2018
Database last updated on 01.04.2026
FormerThe patent has been granted
Status updated on  07.04.2017
FormerGrant of patent is intended
Status updated on  15.11.2016
Most recent event   Tooltip10.07.2020Lapse of the patent in a contracting state
New state(s): AL		published on 12.08.2020  [2020/33]
Applicant(s)For all designated states
Cempra Pharmaceuticals, Inc.
6320 Quadrangle Drive, Suite 360
Chapel Hill, NC 27517 / US
[2016/31]
Former [2013/03]For all designated states
Cempra Pharmaceuticals, Inc.
6340 Quadrangle Drive, Suite 100
Chapel Hill, NC 27517 / US
Inventor(s)01 / PEREIRA, David, E.
103 Lansbrooke Lane
Apex NC 27502 / US
02 / FERNANDES, Prabhavathi
203 Old Franklin Road Drive
Chapel Hill NC 27514 / US
 [2013/03]
Representative(s)Elsy, David, et al
Withers & Rogers LLP
2 London Bridge
London SE1 9RA / GB
[N/P]
Former [2013/03]Elsy, David, et al
Withers & Rogers LLP
4 More London Riverside
London SE1 2AU / GB
Application number, filing date11754115.110.03.2011
[2017/19]
WO2011US27984
Priority number, dateUS20100312417P10.03.2010         Original published format: US 312417 P
[2013/03]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2011112864
Date:15.09.2011
Language:EN
[2011/37]
Type: A1 Application with search report 
No.:EP2544537
Date:16.01.2013
Language:EN
The application published by WIPO in one of the EPO official languages on 15.09.2011 takes the place of the publication of the European patent application.
[2013/03]
Type: B1 Patent specification 
No.:EP2544537
Date:10.05.2017
Language:EN
[2017/19]
Search report(s)International search report - published on:US15.09.2011
(Supplementary) European search report - dispatched on:EP14.04.2014
ClassificationIPC:A01N43/02, A61K31/335, A61K9/00, A61K47/12, A61K47/26, A61K9/19
[2014/20]
CPC:
A61K31/335 (EP,US); A61K47/12 (EP,US); A61K47/26 (EP,US);
A61K9/0019 (EP,US); A61K9/19 (EP,US); A61P11/00 (EP);
A61P13/02 (EP); A61P31/00 (EP); A61P31/04 (EP);
A61P33/00 (EP); A61P33/02 (EP); Y02A50/30 (EP,US) (-)
Former IPC [2013/03]A01N43/02, A61K31/335
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/03]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:PARENTERALE FORMULIERUNGEN AUS MAKROLIDANTIBIOTIKA[2013/03]
English:PARENTERAL FORMULATIONS OF MACROLIDE ANTIBIOTICS[2013/03]
French:FORMULATIONS PARENTÉRALES D'ANTIBIOTIQUES DE LA CLASSE DES MACROLIDES[2013/03]
Entry into regional phase19.09.2012National basic fee paid 
19.09.2012Search fee paid 
19.09.2012Designation fee(s) paid 
19.09.2012Examination fee paid 
Examination procedure19.09.2012Examination requested  [2013/03]
22.12.2014Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time
23.02.2015Amendment by applicant (claims and/or description)
15.02.2016Despatch of a communication from the examining division (Time limit: M06)
22.07.2016Reply to a communication from the examining division
16.11.2016Communication of intention to grant the patent
09.03.2017Fee for grant paid
09.03.2017Fee for publishing/printing paid
09.03.2017Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  15.02.2016
Opposition(s)13.02.2018No opposition filed within time limit [2018/16]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
23.02.2015Request for further processing filed
23.02.2015Full payment received (date of receipt of payment)
Request granted
06.03.2015Decision despatched
Fees paidRenewal fee
27.03.2013Renewal fee patent year 03
27.03.2014Renewal fee patent year 04
10.03.2015Renewal fee patent year 05
09.03.2016Renewal fee patent year 06
29.03.2017Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU10.03.2011
AL10.05.2017
CY10.05.2017
EE10.05.2017
FI10.05.2017
HR10.05.2017
LT10.05.2017
LV10.05.2017
MC10.05.2017
MK10.05.2017
PT10.05.2017
RO10.05.2017
RS10.05.2017
SK10.05.2017
SM10.05.2017
TR10.05.2017
BG10.08.2017
GR11.08.2017
IS10.09.2017
[2020/33]
Former [2020/31]HU10.03.2011
CY10.05.2017
EE10.05.2017
FI10.05.2017
HR10.05.2017
LT10.05.2017
LV10.05.2017
MC10.05.2017
MK10.05.2017
PT10.05.2017
RO10.05.2017
RS10.05.2017
SK10.05.2017
SM10.05.2017
TR10.05.2017
BG10.08.2017
GR11.08.2017
IS10.09.2017
Former [2020/27]HU10.03.2011
EE10.05.2017
FI10.05.2017
HR10.05.2017
LT10.05.2017
LV10.05.2017
MC10.05.2017
PT10.05.2017
RO10.05.2017
RS10.05.2017
SK10.05.2017
SM10.05.2017
TR10.05.2017
BG10.08.2017
GR11.08.2017
IS10.09.2017
Former [2020/15]EE10.05.2017
FI10.05.2017
HR10.05.2017
LT10.05.2017
LV10.05.2017
MC10.05.2017
RO10.05.2017
RS10.05.2017
SK10.05.2017
SM10.05.2017
TR10.05.2017
BG10.08.2017
GR11.08.2017
IS10.09.2017
Former [2018/52]EE10.05.2017
FI10.05.2017
HR10.05.2017
LT10.05.2017
LV10.05.2017
MC10.05.2017
RO10.05.2017
RS10.05.2017
SK10.05.2017
SM10.05.2017
BG10.08.2017
GR11.08.2017
IS10.09.2017
Former [2018/11]EE10.05.2017
FI10.05.2017
HR10.05.2017
LT10.05.2017
LV10.05.2017
RO10.05.2017
RS10.05.2017
SK10.05.2017
SM10.05.2017
BG10.08.2017
GR11.08.2017
IS10.09.2017
Former [2018/10]EE10.05.2017
FI10.05.2017
HR10.05.2017
LT10.05.2017
LV10.05.2017
RO10.05.2017
RS10.05.2017
SK10.05.2017
BG10.08.2017
GR11.08.2017
IS10.09.2017
Former [2018/09]EE10.05.2017
FI10.05.2017
HR10.05.2017
LT10.05.2017
LV10.05.2017
RS10.05.2017
BG10.08.2017
GR11.08.2017
IS10.09.2017
Former [2017/50]FI10.05.2017
HR10.05.2017
LT10.05.2017
LV10.05.2017
RS10.05.2017
BG10.08.2017
GR11.08.2017
IS10.09.2017
Former [2017/49]FI10.05.2017
HR10.05.2017
LT10.05.2017
GR11.08.2017
IS10.09.2017
Documents cited:Search[Y] CN101045063  
 [Y] US2006100164  (LIANG CHANG-HSING et al.) [Y] 1-16 * paragraph [0039] - paragraph [0051] * * paragraph [0202] *
 [Y]   DATABASE WPI Week 200822, Derwent World Patents Index; AN 2008-D02982, XP002722744 [Y] 1-16 * abstract *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.